Remote Patient Monitoring Equipment Market Size, Share & Trends Analysis - Global - 2025-2031 - Includes: Disease Conditions Management Market and Cardiac Implantable Electronic Device Market
Description
Global Remote Patient Monitoring Market Report, 2025 Edition
Executive Summary
The global remote patient monitoring (RPM) market was valued at nearly $5.1 billion in 2024. It is expected to grow at a 10.3 percent CAGR to exceed $10 billion by 2032, making it one of the fastest growing segments in the global patient monitoring landscape. Rapid expansion is driven by demographic shifts, chronic disease prevalence, expansion of telehealth infrastructure, and the increasing need for cost-efficient care delivery inside and outside the hospital.
This report covers the full spectrum of remote patient monitoring technologies, including disease conditions management (DCM) systems and cardiac implantable electronic devices (CIED) monitoring platforms. It quantifies unit sales, average selling prices, market values, growth rates, and company shares. It evaluates drivers, limiters, technological advancements, and strategic developments. Historical data to 2022 and forecasts to 2032 are included.
RPM plays a central role in extending care beyond the hospital. Rising global adoption of telehealth initiatives and the need to reduce readmissions, shorten inpatient stays, and support chronic disease management are accelerating demand. As of 2022, approximately 10 percent of the world’s population is over age 65, a proportion that increases annually. This demographic shift alone significantly contributes to growth, as elderly patients require ongoing surveillance for conditions such as cardiac disease, diabetes, and hypertension.
The report provides comprehensive coverage to support strategic planning, product development, pricing analysis, and competitive positioning for decision-makers in the global RPM market.
Market Overview
Remote patient monitoring enables clinicians to collect real-time health data from patients outside traditional clinical settings. RPM bridges the gap between inpatient, outpatient, and home-based care by providing continuous or scheduled updates on patient conditions. RPM systems typically track vital signs, symptoms, biometric data, and other physiological metrics through connected devices, sensors, and cloud-based platforms.
The global RPM market includes:
Disease conditions management (DCM) systems used for chronic disease surveillance
Cardiac implantable electronic device (CIED) monitoring systems used for automatic transmissions from pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices
Adoption is influenced by several long-term global trends:
Growing elderly populations in all major markets
Increasing chronic disease prevalence
Rising healthcare costs and pressure to reduce inpatient utilization
Expansion of home healthcare
Increased acceptance of telehealth during and after the COVID 19 pandemic
Improvements in cellular networks and cloud-based technologies
RPM has become a strategic priority for hospitals, health systems, home care companies, and government agencies seeking cost-effective ways to manage chronic disease and reduce strain on provider staffing.
Countries with strong wireless infrastructure are among the fastest adopters because RPM requires dependable data transmission. Adoption is particularly strong in the United States, Western Europe, and parts of Asia Pacific.
As healthcare shifts toward personalized and preventive care, RPM plays a critical role in enabling early interventions, continuous surveillance, and individualized monitoring plans that reduce unnecessary hospital visits and improve patient engagement.
Market Drivers
Technological Advancements
Technological progress is the foundation of RPM market growth. Advances in wireless transmission networks, cloud storage, mobile applications, and sensor design have made remote monitoring safer, more reliable, and easier to use. Enhanced interoperability with electronic medical records accelerates clinical workflow integration. Connectivity improvements also allow devices to automatically transmit data to care teams for early warning alerts and proactive management.
Countries with strong wireless infrastructure experience rapid RPM adoption because reliable connectivity is essential for transmitting medical data securely and consistently. As technologies become more efficient, cost-effective, and user-friendly, adoption will continue to rise across clinical specialties and care settings.
Cost Savings for Healthcare Providers
Hospitals, health systems, clinics, and payers are under constant pressure to control costs. Remote monitoring has demonstrated measurable reductions in:
Hospital admissions
Length of stay
Emergency room visits
Unnecessary in-person consultations
RPM supports disease self-management and routine monitoring from home, reducing inpatient resource use. Studies have shown that reductions in hospitalizations result in significant cost savings for health systems. As telehealth initiatives expand worldwide, the economic benefits of RPM have become a major driver of market growth.
This financial incentive is especially important in aging populations, where chronic disease prevalence is high and early intervention is essential to maintaining quality of life.
Demand for Customized Healthcare
As life expectancy increases, patient expectations rise. Many individuals want personalized, data-driven healthcare plans tailored to their specific conditions, lifestyle, and location. RPM platforms support this by enabling physicians and patients to focus on the most relevant parameters. Customized monitoring schedules, condition-specific questions, and automated reminders allow patients to become more involved in their care.
Demand for tailored healthcare solutions will continue to drive RPM adoption because it aligns with broader market shifts toward preventive medicine and value-based care.
Market Limiters
Lack of Reimbursement
In many regions, reimbursement policies for telehealth and RPM remain inconsistent. In areas without reimbursement, the cost burden shifts to patients or healthcare organizations. This is a major barrier to adoption, particularly in developing regions such as Eastern Europe and parts of Latin America.
Sustainable reimbursement frameworks are essential for long-term market expansion. As value-based care models become more prevalent, reimbursement improvements are expected, but this transition remains uneven across global markets.
Interoperability Issues
The telehealth ecosystem is fragmented. Device manufacturers, software vendors, health systems, and telecommunications providers often use incompatible technologies. Without standardized interoperability, RPM platforms struggle to integrate with:
Electronic health records
Hospital information systems
Home networks
Third-party diagnostic devices
Patients and providers prefer technologies with broad compatibility. Proprietary systems that require specific compatible devices limit adoption and slow market growth. Interoperability improvements will be essential for enabling seamless integration across care providers, hospitals, and home environments.
Patient Compliance
The majority of RPM users are over age 65. Many individuals in this demographic did not grow up with digital technologies and may find new systems challenging to use. Devices with complex interfaces, multi-step workflows, or smartphone-dependent setups can create barriers to compliance.
Low compliance can cause gaps in monitoring, reduce clinical effectiveness, and create data inconsistencies. Manufacturers are responding with simplified interfaces, automated transmissions, and voice-enabled instructions. Despite these improvements, patient comfort with technology remains an ongoing market limitation.
Market Coverage and Data Scope
Quantitative Coverage
Market size
Market shares
Units sold
Average selling prices
Market forecasts to 2032
Market growth rates
Qualitative Coverage
Market growth trends
Market limiters
Competitive analysis and SWOT for top competitors
Company profiles and product portfolios
Mergers and acquisitions
FDA recalls
Disruptive technologies
Disease overviews and clinical context
Data Sources
Interviews with industry executives and clinical leaders
Government physician and procedural datasets
Import and export statistics
Hospital private procurement and usage data
Regulatory filings
iData Research internal data models and forecasting methodologies
Markets Covered and Segmentation
Remote Patient Monitoring Market by Device Type
Disease Conditions Management (DCM)
Chronic disease monitoring platforms, mobile medical applications, and connected home diagnostic devices.
Cardiac Implantable Electronic Device (CIED) Monitoring
Systems designed to remotely capture data from pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices.
Segmentation includes unit volumes, ASPs, revenues, and forecast data for each device type.
Competitive Analysis
Medtronic
Medtronic was the leading competitor in the global RPM market in 2024. The company’s position is strengthened by its long-standing partnership with the Veterans Health Administration’s Care Coordination and Home Telehealth program following Bosch Healthcare’s exit. Medtronic offers a comprehensive portfolio of cardiac and remote monitoring solutions across chronic disease categories. This allows Medtronic to compete in both DCM and CIED segments.
Philips Healthcare
Philips Healthcare ranked second. Its eCareCompanion platform delivers remote monitoring through Wi-Fi or cellular connection. Philips benefits from strong brand recognition, extensive global infrastructure, and a broad portfolio that spans multiple monitoring categories. Because RPM is integrated into Philips’ broader patient monitoring ecosystem, the company maintains a cohesive cross-category presence.
Honeywell Life Sciences
Honeywell Life Sciences held the third-leading position. The Genesis Touch v2 platform offers 3G, 4G, and Wi-Fi connectivity and integrates directly with Honeywell’s LifeStream Management Suite. Honeywell’s Genesis DM solution features disease-specific symptom management questions and voice-enabled functions designed to increase compliance. This differentiation strengthens Honeywell’s position among healthcare organizations seeking condition-specific remote care pathways.
Technology and Practice Trends
Expansion of cloud-based telehealth platforms
Integration with mobile applications for patient engagement
Development of multi-sensor wearable devices
Increased use of AI for predictive analytics and early deterioration detection
Growth of home-based chronic disease programs supported by RPM
Adoption of voice-enabled devices for improved user compliance
Increased focus on secure data transmission and cybersecurity
Shift toward interoperable systems that work across vendors and EHR platforms
Improved integration with cardiac implantable device monitoring systems
These trends are shifting RPM from a specialty tool to a mainstream solution used throughout healthcare.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Where is the fastest-growing opportunity in the remote patient monitoring market
How do disease conditions management and cardiac implantable device monitoring differ in adoption and pricing
What factors will influence reimbursement, interoperability, and long-term market expansion
How major competitors differentiate themselves through product portfolios and technology integration
What role do demographic trends and healthcare cost pressures play in driving RPM adoption
How suppliers can use unit and ASP data to plan competitive strategy, pricing, and product development
What risks exist for supply chain, regulatory shifts, and regional differences in telehealth maturity
The Global Remote Patient Monitoring Market Report from iData Research provides the data and analysis needed to quantify global demand, understand market positioning, and plan for growth in one of the most rapidly expanding areas of patient monitoring.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows.
Executive Summary
The global remote patient monitoring (RPM) market was valued at nearly $5.1 billion in 2024. It is expected to grow at a 10.3 percent CAGR to exceed $10 billion by 2032, making it one of the fastest growing segments in the global patient monitoring landscape. Rapid expansion is driven by demographic shifts, chronic disease prevalence, expansion of telehealth infrastructure, and the increasing need for cost-efficient care delivery inside and outside the hospital.
This report covers the full spectrum of remote patient monitoring technologies, including disease conditions management (DCM) systems and cardiac implantable electronic devices (CIED) monitoring platforms. It quantifies unit sales, average selling prices, market values, growth rates, and company shares. It evaluates drivers, limiters, technological advancements, and strategic developments. Historical data to 2022 and forecasts to 2032 are included.
RPM plays a central role in extending care beyond the hospital. Rising global adoption of telehealth initiatives and the need to reduce readmissions, shorten inpatient stays, and support chronic disease management are accelerating demand. As of 2022, approximately 10 percent of the world’s population is over age 65, a proportion that increases annually. This demographic shift alone significantly contributes to growth, as elderly patients require ongoing surveillance for conditions such as cardiac disease, diabetes, and hypertension.
The report provides comprehensive coverage to support strategic planning, product development, pricing analysis, and competitive positioning for decision-makers in the global RPM market.
Market Overview
Remote patient monitoring enables clinicians to collect real-time health data from patients outside traditional clinical settings. RPM bridges the gap between inpatient, outpatient, and home-based care by providing continuous or scheduled updates on patient conditions. RPM systems typically track vital signs, symptoms, biometric data, and other physiological metrics through connected devices, sensors, and cloud-based platforms.
The global RPM market includes:
Disease conditions management (DCM) systems used for chronic disease surveillance
Cardiac implantable electronic device (CIED) monitoring systems used for automatic transmissions from pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices
Adoption is influenced by several long-term global trends:
Growing elderly populations in all major markets
Increasing chronic disease prevalence
Rising healthcare costs and pressure to reduce inpatient utilization
Expansion of home healthcare
Increased acceptance of telehealth during and after the COVID 19 pandemic
Improvements in cellular networks and cloud-based technologies
RPM has become a strategic priority for hospitals, health systems, home care companies, and government agencies seeking cost-effective ways to manage chronic disease and reduce strain on provider staffing.
Countries with strong wireless infrastructure are among the fastest adopters because RPM requires dependable data transmission. Adoption is particularly strong in the United States, Western Europe, and parts of Asia Pacific.
As healthcare shifts toward personalized and preventive care, RPM plays a critical role in enabling early interventions, continuous surveillance, and individualized monitoring plans that reduce unnecessary hospital visits and improve patient engagement.
Market Drivers
Technological Advancements
Technological progress is the foundation of RPM market growth. Advances in wireless transmission networks, cloud storage, mobile applications, and sensor design have made remote monitoring safer, more reliable, and easier to use. Enhanced interoperability with electronic medical records accelerates clinical workflow integration. Connectivity improvements also allow devices to automatically transmit data to care teams for early warning alerts and proactive management.
Countries with strong wireless infrastructure experience rapid RPM adoption because reliable connectivity is essential for transmitting medical data securely and consistently. As technologies become more efficient, cost-effective, and user-friendly, adoption will continue to rise across clinical specialties and care settings.
Cost Savings for Healthcare Providers
Hospitals, health systems, clinics, and payers are under constant pressure to control costs. Remote monitoring has demonstrated measurable reductions in:
Hospital admissions
Length of stay
Emergency room visits
Unnecessary in-person consultations
RPM supports disease self-management and routine monitoring from home, reducing inpatient resource use. Studies have shown that reductions in hospitalizations result in significant cost savings for health systems. As telehealth initiatives expand worldwide, the economic benefits of RPM have become a major driver of market growth.
This financial incentive is especially important in aging populations, where chronic disease prevalence is high and early intervention is essential to maintaining quality of life.
Demand for Customized Healthcare
As life expectancy increases, patient expectations rise. Many individuals want personalized, data-driven healthcare plans tailored to their specific conditions, lifestyle, and location. RPM platforms support this by enabling physicians and patients to focus on the most relevant parameters. Customized monitoring schedules, condition-specific questions, and automated reminders allow patients to become more involved in their care.
Demand for tailored healthcare solutions will continue to drive RPM adoption because it aligns with broader market shifts toward preventive medicine and value-based care.
Market Limiters
Lack of Reimbursement
In many regions, reimbursement policies for telehealth and RPM remain inconsistent. In areas without reimbursement, the cost burden shifts to patients or healthcare organizations. This is a major barrier to adoption, particularly in developing regions such as Eastern Europe and parts of Latin America.
Sustainable reimbursement frameworks are essential for long-term market expansion. As value-based care models become more prevalent, reimbursement improvements are expected, but this transition remains uneven across global markets.
Interoperability Issues
The telehealth ecosystem is fragmented. Device manufacturers, software vendors, health systems, and telecommunications providers often use incompatible technologies. Without standardized interoperability, RPM platforms struggle to integrate with:
Electronic health records
Hospital information systems
Home networks
Third-party diagnostic devices
Patients and providers prefer technologies with broad compatibility. Proprietary systems that require specific compatible devices limit adoption and slow market growth. Interoperability improvements will be essential for enabling seamless integration across care providers, hospitals, and home environments.
Patient Compliance
The majority of RPM users are over age 65. Many individuals in this demographic did not grow up with digital technologies and may find new systems challenging to use. Devices with complex interfaces, multi-step workflows, or smartphone-dependent setups can create barriers to compliance.
Low compliance can cause gaps in monitoring, reduce clinical effectiveness, and create data inconsistencies. Manufacturers are responding with simplified interfaces, automated transmissions, and voice-enabled instructions. Despite these improvements, patient comfort with technology remains an ongoing market limitation.
Market Coverage and Data Scope
Quantitative Coverage
Market size
Market shares
Units sold
Average selling prices
Market forecasts to 2032
Market growth rates
Qualitative Coverage
Market growth trends
Market limiters
Competitive analysis and SWOT for top competitors
Company profiles and product portfolios
Mergers and acquisitions
FDA recalls
Disruptive technologies
Disease overviews and clinical context
Data Sources
Interviews with industry executives and clinical leaders
Government physician and procedural datasets
Import and export statistics
Hospital private procurement and usage data
Regulatory filings
iData Research internal data models and forecasting methodologies
Markets Covered and Segmentation
Remote Patient Monitoring Market by Device Type
Disease Conditions Management (DCM)
Chronic disease monitoring platforms, mobile medical applications, and connected home diagnostic devices.
Cardiac Implantable Electronic Device (CIED) Monitoring
Systems designed to remotely capture data from pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices.
Segmentation includes unit volumes, ASPs, revenues, and forecast data for each device type.
Competitive Analysis
Medtronic
Medtronic was the leading competitor in the global RPM market in 2024. The company’s position is strengthened by its long-standing partnership with the Veterans Health Administration’s Care Coordination and Home Telehealth program following Bosch Healthcare’s exit. Medtronic offers a comprehensive portfolio of cardiac and remote monitoring solutions across chronic disease categories. This allows Medtronic to compete in both DCM and CIED segments.
Philips Healthcare
Philips Healthcare ranked second. Its eCareCompanion platform delivers remote monitoring through Wi-Fi or cellular connection. Philips benefits from strong brand recognition, extensive global infrastructure, and a broad portfolio that spans multiple monitoring categories. Because RPM is integrated into Philips’ broader patient monitoring ecosystem, the company maintains a cohesive cross-category presence.
Honeywell Life Sciences
Honeywell Life Sciences held the third-leading position. The Genesis Touch v2 platform offers 3G, 4G, and Wi-Fi connectivity and integrates directly with Honeywell’s LifeStream Management Suite. Honeywell’s Genesis DM solution features disease-specific symptom management questions and voice-enabled functions designed to increase compliance. This differentiation strengthens Honeywell’s position among healthcare organizations seeking condition-specific remote care pathways.
Technology and Practice Trends
Expansion of cloud-based telehealth platforms
Integration with mobile applications for patient engagement
Development of multi-sensor wearable devices
Increased use of AI for predictive analytics and early deterioration detection
Growth of home-based chronic disease programs supported by RPM
Adoption of voice-enabled devices for improved user compliance
Increased focus on secure data transmission and cybersecurity
Shift toward interoperable systems that work across vendors and EHR platforms
Improved integration with cardiac implantable device monitoring systems
These trends are shifting RPM from a specialty tool to a mainstream solution used throughout healthcare.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Where is the fastest-growing opportunity in the remote patient monitoring market
How do disease conditions management and cardiac implantable device monitoring differ in adoption and pricing
What factors will influence reimbursement, interoperability, and long-term market expansion
How major competitors differentiate themselves through product portfolios and technology integration
What role do demographic trends and healthcare cost pressures play in driving RPM adoption
How suppliers can use unit and ASP data to plan competitive strategy, pricing, and product development
What risks exist for supply chain, regulatory shifts, and regional differences in telehealth maturity
The Global Remote Patient Monitoring Market Report from iData Research provides the data and analysis needed to quantify global demand, understand market positioning, and plan for growth in one of the most rapidly expanding areas of patient monitoring.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows.
Table of Contents
53 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
